Follow

Submissions from 2002

Updates in treatment of hypertension: Part 1, C. T. Herring

ValHEFT trial review: How will this change practice standards?, C. T. Herring

Clinical validity of Headache Impact Test (HIT) among adolescents using patient-reported headache characteristics, W. J. Kwong, W. M. Moore, R. Cady, M. Bayliss, J. Bjorner, and A. S. Batenhorst

Impact of an increase in prescription co-payment on drug utilization, B. L. Meissner, W. M. Moore, J. A. Shinogle, C. E. Reeder, and J. M. Little

Headache Impact Test (HIT) provides sensitivity in differentiating impact levels across the spectrum of headache frequency & severity, W. M. Moore, W. J. Kwong, C. G. Dahlof, R. Cady, A. S. Batenhorst, B. W. Bowers, and M. S. Bayliss

Profile of adolescent headache sufferers completing the Headache Impact Test (HIT) via the Internet, W. M. Moore, W. J. Kwong, S. Tepper, M. Diamond, M. Bayliss, and A. S. Batenhorst

Sensitivity of Headache Impact Test (HIT) in distinguishing headache impact among headache sufferers receiving pharmacological treatment, W. M. Moore, W. J. Kwong, S. J. Tepper, B. W. Bowers, A. S. Batenhorst, and M. S. Bayliss

Assisting the patient with Alzheimer's disease, A. M. Nye

Changes of aging, A. M. Nye

Clinical pharmacy involvement in home based primary care, A. M. Nye

Drug-related problems in the elderly, A. M. Nye

Performance improvement of drug related documentation in home based primary care, A. M. Nye

HIV therapy: An update CE, M. W. Pound

The role of angiotensin-receptor blockers in heart failure CE, M. W. Pound

Personal digital assistants as a resource for pharmacy students during experiential learning, M. W. Pound, R. H. Drew, and D. B. May

Personal digital assistants (PDAs) as a resource for pharmacy students during experiential learning, M. W. Pound, R. H. Drew, and D. B. May

Personal digital assistants (PDAs) as a resource for pharmacy students during experiential learning, M. W. Pound, R. H. Drew, and D. B. May

Recent advances in the epidemiology, prevention, diagnosis, and treatment of fungal pneumonia, M. W. Pound, R. H. Drew, and J. R. Perfect

The use of HMG-CoA reductase inhibitors in osteoporosis, A. A. Richard and T. M. Harrison

The use of HMG-CoA reductase inhibitors in osteoporosis, A. A. Richard and T. H. Thornhill

Antimicrobial overview: A training session, K. B. Rumley

Review of antifungal agents, K. B. Rumley

Sinusitis and Bronchitis, K. B. Rumley

Why Cipro and Avelox?, K. B. Rumley

Community pharmacy research projects – the evolution of a required course, T. H. Thornhill and L. N. Swanson

Community pharmacy research projects – the evolution of a required course, T. H. Thornhill and L. N. Swanson

Anticoagulation and enoxaparin use in patients with prosthetic heart valves and/or pregnancy. Report and Recommendations of the Anticoagulation in Prosthetic Valves and Pregnancy Consensus Report (APPCR) Panel and Scientific Roundtable, E. J. Topol, G. Bosker, H. Cassele, U. Elkayam, S. Z. Goldhaber, R. A. Grimm, J. B. Groce, J. A. Heit, A. James, A. L. Klein, C. Lockwood, G. Merli, C. Pollack, S. A. Spinler, and A. G. Turpie

Submissions from 2001

Evaluation of a computer program for standardizing oral anticoagulation therapy; A new tool for the anticoagulation care provider, K. Baker, J. B. Groce, and D. Patriss

Special report: supporting patient self-care for osteoarthritis, K. D. Brandt, M. Dewey, T. M. Harrison, and R. E. Small

Special report: supporting patient self-care for osteoarthritis, K. D. Brandt, M. Dewey, T. H. Thornhill, and R. E. Small

Antithrombotic therapy in the long-term care setting: Reassessing the risk of deep venous thrombosis and pulmonary embolism in the acutely ill medical patient, J. W. Cooper and J. B. Groce

DVT prophylaxis in medically ill patients: A new avenue of clinical management in the long-term care setting, J. W. Cooper and J. B. Groce

Impact of a pharmacy student-based inpatient Pneumococcal vaccination program, E. S. Dodds, R. H. Drew, D. B. May, J. B. Washam, J. A. Gouveia-Pisano, K. B. Rumley, and B. Luna

Impact of a pharmacy student-based inpatient pneumococcal vaccination program, E. S. Dodds, D. B. May, J. A. Gouveia-Pisano, J. B. Washam, K. B. Fulton, and B. Luna

Ask the pharmacist- Lipids, herbs, weight loss medications, etc., S. H. Fuller

COX-2 inhibitors: Efficacy, safety, CV death?, S. H. Fuller

COX-2 inhibitors: Efficacy, safety, CV death?, S. H. Fuller

Current concepts on Systemic Lupus Erythematosus, S. H. Fuller

A case for the use of low-molecular-weight-heparin: the pharmacoeconomics of LMWHs-making the case, J. B. Groce

Heparin and low molecular weight heparin, J. B. Groce

Low-Molecular-Weight-Heparin differentiation: Issues and evolving evidence, J. B. Groce

Outpatient treatment of deep vein thrombosis with low-molecular-weight-heparins, J. B. Groce

Thromboembolic disease, J. B. Groce

Treatment of deep vein thrombosis using low-molecular-weight heparins, J. B. Groce

Evaluation of a new tool for the anticoagulation care provider: A computer program for standardizing oral anticoagulation therapy, J. B. Groce, K. R. Baker, D. D. Patriss, D. Cender, and et al.

The pharmacoeconomics of LMWHs: Getting the most “bang for the health care buck”, J. B. Groce and J. W. Cooper

Thromboembolic disease: Evolving evidence of clinical consensus and differentiation of low-molecular-weight-heparins, J. B. Groce and S. T. Hains

Treatment of deep vein thrombosis using low-molecular weight heparins, J. B. Groce, B. Perler, V. Tapson, and et al.

Annual credentialing in basic skills / requirements, C. T. Herring

NCEP 3 dyslipidemia guideline review, C. T. Herring

Applying scientific criteria to therapeutic interchange: A balanced analysis of low-molecular-weight heparins, G. J. Merlie, G. J. Vanscoy, T. L. Rihn, and J. B. Groce

Thrombotic complications in the acute medically ill: Update for the medical director, B. Perler, J. B. Groce, and B. L. Hoffman

Telithromycin CE, M. W. Pound

The use of fluoroquinolones in respiratory tract infections, focus: Moxifloxacin, M. W. Pound

Update on antimicrobial therapy, K. B. Rumley

OTC drugs: otic, dental, & ophthalmic agents, L. Swanson, C. L. Barnes, and T. H. Thornhill

OTC drugs: menstrual, vaginal, & contraceptive agents, L. Swanson, M. Scott, and T. H. Thornhill

OTC drugs: weight control, sleep aids, & smoking cessation, L. Swanson and T. H. Thornhill

HMG-CoA reductase inhibitors and Rhabdomyolysis – a clinicians guide to safe use, T. H. Thornhill

Lactobacillus Endocarditis: A case report, L. E. Warrick and K. B. Rumley

Submissions from 2000

An evaluation of the use of Beers’ Criteria drugs among community dwelling elderly patients, J. Creger, T. H. Thornhill, A. Graffius, H. Nunn, and M. White

Special report: management of osteoarthritis, S. L. Dahl, T. H. Thornhill, D. A. Hussar, and R. E. Loeser

Pharmacy students initiating Pneumococcal vaccination, E. S. Dodds, R. H. Drew, D. B. May, J. Washam, J. A. Gouveia-Pisano, B. Luna, and K. B. Fulton

Recent changes in vaccination guidelines: an update on vaccines and target population initiatives, E. S. Dodds, D. B. May, and R. H. Drew

Assessment of the appropriateness of medication prescribing in geriatric inpatients, R. Edwards, T. H. Thornhill, and D. M. Davis

Faculty resource guide development, M. A. Fritsch, T. M. Harrison, S. H. Fuller, C. C. DaCamara, and D. B. May

Faculty Resource Guide Development, M. A. Fritsch, T. M. Harrison, S. H. Suller, C. C. da Camara, and D. B. May

The Faculty Research Orientation Group (FROG), M. Fritsch, T. H. Thornhill, S. Fuller, C. da Camara, and B. May

Systemic Lupus Erythematosus, S. H. Fuler and C. D. daCamara

Awareness of CAD risk factors, S. H. Fuller

Case studies in hyperlipidemia, S. H. Fuller

The perceived influence of advertising on the selection of OTC medications and herbs, S. H. Fuller

Monitoring of patients on lipid medications in the community, S. H. Fuller, A. Williams, K. Bova, A. Teague-Deaton, S. H. Fuller, and R. W. Chater

Does size* really matter? (*milligram strength of initial dose of oral anticoagulation), J. B. Groce

Pharmacoeconomics of switching LMWHs: process of recent examination by pharmacy and therapeutics committee, Moses Cone Health System, J. B. Groce

Trimethoprim-Sulfamethoxazole, D. B. May

Improvement of transaminase monitoring in patients on troglitazone therapy by clinical pharmacists in a Veterans Affairs primary care clinic, D. Neal, C. T. Herring, and K. Neal

Inappropriate prescribing in elderly members of a medicare supplemental insurance plan, A. M. Nye

Preparation of sterile products for latex sensitive patients, A. M. Nye

Consequences and contributing factors to potentially inappropriate prescribing in the elderly, A. M. Nye; M. A, Pyles; and P. W. Slattum

Consequences and contributing factors to potentially inappropriate prescribing in the elderly, A. M. Nye, M. A. Pyles, and P. W. Slattum

Lactobacillus Endocarditis, K. B. Rumley

Medical management of obesity, K. B. Rumley

OTC treatment of obesity, K. B. Rumley

Treating mammalian bite wounds, P. F. Smith, A. M. Meadowcroft, and D. B. May

Contemporary issues in the management of Osteoarthritis, T. H. Thornhill

Herbs to the wise, T. H. Thornhill

Submissions from 1999

Conventional and alternative therapies for the treatment of hyperlipidemia, S. H. Fuller

Conventional and alternative therapies for the treatment of hyperlipidemia, S. H. Fuller

Getting to the heart of diabetes, S. H. Fuller

Update of the treatment of hyperlipidemia, S. H. Fuller

Efficacy and safety of low molecular weight heparin determined by heparin level assay for the continued outpatient treatment of pulmonary embolism in a morbidly obese pregnant patient, D. Javino and J. B. Groce

Implementing outpatient treatment of deep vein thrombosis, K. Kitchens, G. Merli, J. B. Groce, and S. Biby

Tetracyclines, D. B. May

Cholesterol management in the diabetes patient, E. P. Mills

Osteoporosis prevention: Are we falling down on the job?, E. P. Mills

Skin disorders of Diabetes mellitus, E. P. Mills

1998 Center for Disease Control treatment guidelines for sexually transmitted diseases (Part II), W. M. Moore

Cost-effectiveness of Tolcapone (Tasmar) vs. Ropinirole (Requip) patients on levodopa therapy from a payer perspective, A. M. Nye, W. Garnett, D. Holdford, and N. Carroll

Interpreting laboratory values for the pharmacist, K. B. Rumley